GenVault

GenVault

Room-temperature biosample storage and management

Overview

GenVault stores and manages biological samples and genetic material at room temperature, offering a cost- and space-efficient alternative to traditional freezer storage. Its product lineup includes chemically treated papers and plates for collecting and storing samples, plus automated systems for handling, archiving, and retrieving them. The core idea is to stabilize DNA and RNA without refrigeration so samples stay viable over the long term, even in power outages. This differentiates GenVault from competitors by combining ambient-temperature preservation with automated sample management, reducing energy use and freezer maintenance costs. The company aims to provide scalable, reliable biosample storage and management that supports longitudinal research, drug discovery, and clinical diagnostics while cutting environmental and financial costs.

Significant Headcount Growth

About GenVault

Simplify's Rating
Why GenVault is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Robotics & Automation

Industrial & Manufacturing

Biotechnology

Healthcare

Company Size

11-50

Company Stage

Acquired

Total Funding

$85.6M

Headquarters

West Deptford Township, New Jersey

Founded

2001

Get referred to GenVault

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • GenVault announced Diligent Pharma partnership in 2024, validated by global regulatory audit standards.
  • Blood Cancer United sponsorship in February 2026 expands brand visibility and referral channels.
  • Andrew Lee's 2023 turnaround and 64% efficiency gain suggest stronger operating discipline.

What critics are saying

  • Azenta cut fiscal 2026 organic growth guidance to minus 2% to plus 1% in May 2026.
  • Azenta pushed long-range plan timing from 2028 to 2029, signaling execution slippage.
  • BioStore IIIv launched in 2026 strengthens automated cold storage, commoditizing GenVault's differentiation.

What makes GenVault unique

  • GenVault runs five-floor, 500,000-square-foot biorepository space in West Deptford, 2026.
  • Its platform spans ambient, CRT, frozen, ULT, and cryogenic storage under one roof.
  • GenVault waived storage fees through 2026, signaling aggressive customer acquisition and utilization leverage.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$85.6M

Meets

Industry Average

Funded Over

8 Rounds

Acquisition funding comparison data is currently unavailable. We're working to provide this information soon!
Acquisition Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Company Paid Short-Term Disability

Company Paid Long-Term Disability

Accident/Critical Illness/Hospital Insurance

Pet Insurance Options

PTO

401K with Employer Match

Growth & Insights and Company News

Headcount

6 month growth

26%

1 year growth

26%

2 year growth

26%
Google
Aug 9th, 2023
GenVault Biorepository Announces Executive Director Appointment

WEST DEPTFORD, N.J., August 09, 2023--( BUSINESS WIRE )-- GenVault, one of the nation's most secure, comprehensive commercial facilities for bioinventory storage and transport, announces the appointment of Andrew Lee as executive director.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for GenVault right now.

Find jobs on Simplify and start your career today

We update GenVault's jobs every few hours, so check again soon! Browse all jobs →